HIMS News

Kaplan Fox Announces a Securities Class Action Against Hims & Hers Health, Inc. (NYSE: HIMS) – Lead Plaintiff Deadline is November 2, 2026

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Kahn Swick & Foti, LLC Alerts Shareholders to Class Action Filed Against Hims & Hers Health, Inc. – HIMS

Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS

Compounding Pharmacy Market worth $21.01 billion by 2031 - Exclusive Report by MarketsandMarkets™

HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS

INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - HIMS

Pomerantz LLP Issues Reminder to Shareholders in Hims & Hers Health, Inc. of Class Action Filing – HIMS

Robbins LLP Reminds HIMS Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action